Search

Lynton's Innovative Trade-In Program Promotes Sustainability and Supports NHS Decarbonisation Efforts

Laser manufacturer Lynton is thrilled to announce the Great CO2 Trade-In! A ground-breaking incentive for the ENT sector of the NHS, the Great CO2 Trade-In enables hospitals to trade in their current CO2 surgical lasers for a SmartXide Trio, regardless of the manufacturer.

Enhancing surgical outcomes in TOETVA – with neuromonitoring essentials by Langer Medical

Intraoperative neuromonitoring has become a standard practice in all thyroid surgery, allowing for the precise localisation and reliable monitoring of neurophysiological structures at-risk.

Neuromod advances multiple regulatory approvals to expedite Lenire’s global availability

Neuromod, the medical technology company that created the Lenire® tinnitus treatment device, has announced approval to the Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification. Neuromod’s MDSAP certification follows a comprehensive audit verifying compliance with...

The DEKA SmartXide CO2 Laser is cited in recent paper "Transoral robotic surgery using CO2 Laser in oropharyngeal squamous cell carcinoma: a clinical case series”

The UK government's new 10-year cancer strategy delivering plans to significantly improve cancer survival through earlier diagnosis and faster access to treatment means a commitment to rapidly expanding the use of robotic surgery across the NHS; the ability of devices...